No Data
Japan Data Science Consortium: Revised Semi-Annual Report - Term 7 (2024/07/01 to 2025/06/30)
Japan Data Science Consortium: Correction confirmation
Japan Data Science Consortium: (Correction) Partial Corrections to the “Summary of Financial Results for the 2nd Quarter (Interim Period) for the Fiscal Year Ending June 2025 [Japanese GAAP] (Consolidated)” and “Financial Results Explanator...
Spot information on individual stocks (2)
TOPPAN <7911.T> significantly increases. The consolidated net profit Financial Estimates for this March term have been raised. Lion <4912.T> rebounds sharply. The consolidated operating profit Financial Estimates for this December term is 35 billion yen (a 23% increase compared to the previous term). JDSC <4418.T> hits the upper limit. The consolidated operating profit Financial Estimates for this June term has been revised upward from 300 million yen to 500 million yen (ten times that of the previous term). IHI <7013.T> is sluggish. President Trump has conducted a trilateral meeting with the leaders of Russia and China, discussing an agreement for the three countries to halve their defense spending.
Growth 250 continues to decline, Trial hits a stop loss – Emerging Markets, 14th.
The Tokyo Stock Exchange Growth Market 250 Index continues to decline. Trial Holdings <141A.T> has hit the stop limit, and Cover <5253.T> and Exawizards <4259.T> have also seen significant drops. The decline of major stocks has had an impact. On the other hand, Laboro.AI <5586.T>, Renascience <4889.T>, and JDSC <4418.T> have risen sharply. Free <4478.T> also performed steadily. In the Standard segment, Columbia Works <146A.T> saw a significant increase.
Japan Data Science Consortium: Half Year Report - Term 7 (2024/07/01 - 2025/06/30)